SUMMIT SECURITIES GROUP LLC
Broker-DealerPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1531593
NEW YORK, NY
Position in REGN
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$106,624
-$131,111 QoQ
Shares Held
138
-55.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUMMIT SECURITIES GROUP LLC holds $2,866,317 across 26 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
14,000 | $1,865,640 | |
| 2 | INSM |
INSMED Inc
|
3,800 | $405,156 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
750 | $86,002 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
148 | $79,468 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
971 | $79,146 | |
| 6 | CGON |
CG Oncology, Inc.
|
976 | $69,344 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
543 | $60,289 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
634 | $39,903 |
All Filings in REGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $106,624 | 138 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $237,735 | 308 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $15,743 | 28 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $13,534 | 19 | Shares | Sole | 2025-02-12 | |
| 2024-06-30 | $14,714 | 14 | Shares | Sole | 2024-07-26 | |
| 2023-12-31 | $7,904 | 9 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,875 | 12 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $25,148 | 35 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $290,014 | 421 | Shares | Sole | 2022-11-02 | |
| 2022-03-31 | $335,940 | 481 | Shares | Sole | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||